Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,449,000 | 7,890,000 | 6,017,000 | 41,142,000 | 39,924,000 |
| Marketable Securities | 30,000 | 60,000 | 23,000 | N/A | N/A |
| Receivables | 8,822,000 | 8,416,000 | 8,354,000 | 6,362,000 | 5,428,000 |
| Inventories | 3,310,000 | 3,474,000 | 4,059,000 | 1,844,000 | 1,813,000 |
| TOTAL | $24,173,000 | $23,009,000 | $21,256,000 | $51,758,000 | $49,519,000 |
| Non-Current Assets | |||||
| PPE Net | 5,248,000 | 4,986,000 | 4,908,000 | 2,961,000 | 2,962,000 |
| Investments And Advances | 293,000 | 246,000 | 225,000 | 78,000 | 93,000 |
| Intangibles | 116,000,000 | 117,444,000 | 119,132,000 | 33,764,000 | 34,253,000 |
| Other Non-Current Assets | 4,851,000 | 3,936,000 | 4,009,000 | 2,638,000 | 2,288,000 |
| TOTAL | $126,392,000 | $126,612,000 | $128,274,000 | $39,441,000 | $39,596,000 |
| Total Assets | $150,565,000 | $149,621,000 | $149,530,000 | $91,199,000 | $89,115,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,502,000 | 4,777,000 | 5,371,000 | 3,762,000 | 3,753,000 |
| Accounts payable and accrued liabilities | 20,159,000 | 19,404,000 | 19,275,000 | 12,709,000 | 11,832,000 |
| TOTAL | $28,661,000 | $24,181,000 | $24,646,000 | $16,471,000 | $15,585,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 77,554,000 | 82,282,000 | 82,061,000 | 63,284,000 | 62,975,000 |
| Other Non-Current Liabilities | 27,605,000 | 23,379,000 | 23,307,000 | 17,900,000 | 17,597,000 |
| TOTAL | $108,807,000 | $110,151,000 | $110,152,000 | $82,143,000 | $81,702,000 |
| Total Liabilities | $137,468,000 | $134,332,000 | $134,798,000 | $98,614,000 | $97,287,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,765,882 | 1,765,474 | 1,764,833 | 1,476,742 | 1,479,157 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 1,055,000 | 3,335,000 | 3,130,000 | 5,973,000 | 4,717,000 |
| Other shareholders' equity | -3,096,000 | -3,240,000 | -3,411,000 | -3,697,000 | -3,596,000 |
| TOTAL | $13,097,000 | $15,289,000 | $14,732,000 | $-7,415,000 | $-8,172,000 |
| Total Liabilities And Equity | $150,565,000 | $149,621,000 | $149,530,000 | $91,199,000 | $89,115,000 |